These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

398 related articles for article (PubMed ID: 33824447)

  • 21. Early Cumulative Supplemental Oxygen Predicts Bronchopulmonary Dysplasia in High Risk Extremely Low Gestational Age Newborns.
    Wai KC; Kohn MA; Ballard RA; Truog WE; Black DM; Asselin JM; Ballard PL; Rogers EE; Keller RL;
    J Pediatr; 2016 Oct; 177():97-102.e2. PubMed ID: 27470692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia.
    Procianoy RS; Hentges CR; Silveira RC
    Am J Perinatol; 2016 Apr; 33(5):480-5. PubMed ID: 26529476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early Empirical Antibiotics and Adverse Clinical Outcomes in Infants Born Very Preterm: A Population-Based Cohort.
    Vatne A; Hapnes N; Stensvold HJ; Dalen I; Guthe HJ; Støen R; Brigtsen AK; Rønnestad AE; Klingenberg C;
    J Pediatr; 2023 Feb; 253():107-114.e5. PubMed ID: 36179887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neonatal outcome of small for gestational age preterm infants.
    Nobile S; Marchionni P; Carnielli VP
    Eur J Pediatr; 2017 Aug; 176(8):1083-1088. PubMed ID: 28660312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of Corticosteroid Therapy and Death or Disability According to Pretreatment Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Jensen EA; Wiener LE; Rysavy MA; Dysart KC; Gantz MG; Eichenwald EC; Greenberg RG; Harmon HM; Laughon MM; Watterberg KL; Walsh MC; Yoder BA; Lorch SA; DeMauro SB;
    JAMA Netw Open; 2023 May; 6(5):e2312277. PubMed ID: 37155165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Time Interval between Extubation and Reintubation on Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants.
    Shalish W; Kanbar L; Kovacs L; Chawla S; Keszler M; Rao S; Panaitescu B; Laliberte A; Precup D; Brown K; Kearney RE; Sant'Anna GM
    J Pediatr; 2019 Feb; 205():70-76.e2. PubMed ID: 30404739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality after 36 weeks postmenstrual age of extremely preterm infants in neonatal care: The impact of growth impairment and bronchopulmonary dysplasia.
    Dassios T; Williams E; Hickey A; Bhat R; Greenough A
    Early Hum Dev; 2022 Aug; 171():105618. PubMed ID: 35759944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early energy and protein intakes and associations with growth, BPD, and ROP in extremely preterm infants.
    Klevebro S; Westin V; Stoltz Sjöström E; Norman M; Domellöf M; Edstedt Bonamy AK; Hallberg B
    Clin Nutr; 2019 Jun; 38(3):1289-1295. PubMed ID: 29885776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low caloric intake and high fluid intake during the first week of life are associated with the severity of bronchopulmonary dysplasia in extremely low birth weight infants.
    Al-Jebawi Y; Agarwal N; Groh Wargo S; Shekhawat P; Mhanna MJ
    J Neonatal Perinatal Med; 2020; 13(2):207-214. PubMed ID: 31771083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preeclampsia and risk of developing bronchopulmonary dysplasia in very preterm neonates.
    Wilmink FA; Reijnierse J; Reiss IKM; Steegers EAP; de Jonge RCJ;
    Pregnancy Hypertens; 2019 Jan; 15():57-63. PubMed ID: 30825928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postnatal Cytomegalovirus Infection and the Risk for Bronchopulmonary Dysplasia.
    Kelly MS; Benjamin DK; Puopolo KM; Laughon MM; Clark RH; Mukhopadhyay S; Benjamin DK; Smith PB; Permar SR
    JAMA Pediatr; 2015 Dec; 169(12):e153785. PubMed ID: 26642118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of fluid balance on outcomes in critically ill near-term/term neonates: a report from the AWAKEN study group.
    Selewski DT; Akcan-Arikan A; Bonachea EM; Gist KM; Goldstein SL; Hanna M; Joseph C; Mahan JD; Nada A; Nathan AT; Reidy K; Staples A; Wintermark P; Boohaker LJ; Griffin R; Askenazi DJ; Guillet R;
    Pediatr Res; 2019 Jan; 85(1):79-85. PubMed ID: 30237572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death Among Extremely Preterm Infants: The SAIL Randomized Clinical Trial.
    Kirpalani H; Ratcliffe SJ; Keszler M; Davis PG; Foglia EE; Te Pas A; Fernando M; Chaudhary A; Localio R; van Kaam AH; Onland W; Owen LS; Schmölzer GM; Katheria A; Hummler H; Lista G; Abbasi S; Klotz D; Simma B; Nadkarni V; Poulain FR; Donn SM; Kim HS; Park WS; Cadet C; Kong JY; Smith A; Guillen U; Liley HG; Hopper AO; Tamura M;
    JAMA; 2019 Mar; 321(12):1165-1175. PubMed ID: 30912836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
    Bassler D
    Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A retrospective cohort study on the correlation between early energy management and bronchopulmonary dysplasia in premature infants].
    Lin Q; Mu YJ; Song Y; Wang H
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):239-244. PubMed ID: 38378285
    [No Abstract]   [Full Text] [Related]  

  • 37. Ventilation and respiratory outcome in extremely preterm infants: trends in the new millennium.
    Regin Y; Gie A; Eerdekens A; Toelen J; Debeer A
    Eur J Pediatr; 2022 May; 181(5):1899-1907. PubMed ID: 35034202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Late Onset Arterial Hypotension on Respiratory Outcome in Extremely Premature Infants.
    Kurtom W; Jain D; Quan M; Vanbuskirk S; Bancalari E; Claure N
    Neonatology; 2019; 115(2):164-168. PubMed ID: 30485857
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intratracheal Instillation of Budesonide-Surfactant for Prevention of Bronchopulmonary Dysplasia in Extremely Premature Infants.
    Dolma K; Zayek M; Gurung A; Eyal F
    Am J Perinatol; 2024 May; 41(S 01):e3065-e3073. PubMed ID: 37913780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in the patterns of respiratory support and incidence of bronchopulmonary dysplasia; a single center experience.
    Algarni SS; Ali K; Alsaif S; Aljuaid N; Alzahrani R; Albassam M; Alanazi R; Alqueflie D; Almutairi M; Alfrijan H; Alanazi A; Ghazwani A; Alshareedah S; Alotaibi TF; Alqahtani MM; Aljohani H; Ismaeil TT; Alwadeai KS; Siraj RA; Alsaif A; Asiri S; Halabi S; Alanazi AMM
    BMC Pediatr; 2023 Jul; 23(1):357. PubMed ID: 37442954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.